Home › NDC Lookup › RxCUI directory › RxCUI 1657183

Lanolin 300 MG/ML Topical Cream — RxCUI 1657183

RxNorm drug concept · Semantic clinical drug
RxCUI 1657183 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1657183
Official nameLanolin 300 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslanolin 30 % Topical Cream
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Lanolin 300 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lanolin 300 MG/ML Topical Cream RxCUI 1657183

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lanolin 6227
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lantiseptic 1038918
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lanolin Topical Cream 730936
    • Lanolin Topical Product 1162829
    • Lanolin Topical Cream [Lantiseptic] 1038920
    • Lantiseptic Topical Product 1175623
    • Topical Cream 316982
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Lanolin 300 MG/ML 1657182
    • Lanolin 300 MG/ML Topical Cream [Lantiseptic] 1657185
    • Lanolin 300 MG/ML [Lantiseptic] 1657184

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Lanolin 300 MG/ML SCDC · 1657182
  • Lanolin Topical Cream SCDF · 730936
  • Lanolin Topical Product SCDG · 1162829

Brand-Name Concepts

  • Lanolin 300 MG/ML Topical Cream [Lantiseptic] SBD · 1657185
  • Lanolin 300 MG/ML [Lantiseptic] SBDC · 1657184
  • Lanolin Topical Cream [Lantiseptic] SBDF · 1038920
  • Lantiseptic Topical Product SBDG · 1175623
  • Lantiseptic BN · 1038918

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1657183 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55681-0028-04 113 g in 1 TUBE (55681-028-04) ProCure LanaCare Twin Med LLC 2025-09-15
55681-0028-14 144 PACKET in 1 CARTON (55681-028-14) / 5 g in 1 PACKET (55... ProCure LanaCare Twin Med LLC 2025-09-15
Observed labelers: Twin Med LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.